Cargando…

Short-term outcomes of COVID-19 and risk factors for progression

With a median (IQR) follow-up time of 24.0 (17.5–30.0) days, progression occurred in 19.6% moderate, 27.8% severe and 66.7% critical COVID-19. Neutrophil-to-lymphocyte ratio ≥2.973, age ≥50 years, male sex and comorbidity were associated with progression. https://bit.ly/3crsJr0

Detalles Bibliográficos
Autores principales:	Long, Li, Zeng, Xiansheng, Zhang, Xu, Xiao, Wei, Guo, E, Zhan, Wenzhi, Yang, Xuejiao, Li, Chunyan, Wu, Caiyun, Xu, Tingting, Zhan, Chen, Chen, Yuehan, Jiang, Mei, Zhong, Nanshan, Lai, Kefang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173674/ https://www.ncbi.nlm.nih.gov/pubmed/32312863 http://dx.doi.org/10.1183/13993003.00990-2020

Ejemplares similares

Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19)
por: Chen, Yuehan, et al.
Publicado: (2022)

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge
por: Mo, Xiaoneng, et al.
Publicado: (2020)

Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients
por: Gao, Yi, et al.
Publicado: (2021)

Association of short-term exposure to air pollution with emergency visits for respiratory diseases in children
por: He, Miao, et al.
Publicado: (2022)

A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019
por: Ji, Mengyao, et al.
Publicado: (2020)

Respiratory decline is integral to disease progression in Huntington's disease
por: Jones, Una, et al.
Publicado: (2016)

Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project
por: Dirikgil, Ebru, et al.
Publicado: (2021)

The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
por: Sun, Thomas Yang, et al.
Publicado: (2022)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Du, Rong-Hui, et al.
Publicado: (2020)

Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
por: Wells, Charles D., et al.
Publicado: (2015)

The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China
por: Yang, Kai, et al.
Publicado: (2020)

Association between age and clinical characteristics and outcomes of COVID-19
por: Liu, Yang, et al.
Publicado: (2020)

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
por: Yu, Hai-qiong, et al.
Publicado: (2020)

The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region
por: Chiang, Chen-Yuan, et al.
Publicado: (2020)

Impaired pulmonary function in discharged patients with COVID-19: more work ahead
por: Chen, Ruchong, et al.
Publicado: (2020)

Supporting progress towards the post-2015 targets and regional tuberculosis elimination: a statement of intent from the third meeting of the Asian TB Experts Community
por: Mori, Toru, et al.
Publicado: (2015)

Clinical application of an intelligent oropharyngeal swab robot: implication for the COVID-19 pandemic
por: Li, Shao-Qiang, et al.
Publicado: (2020)

Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
por: Bi, Jianping, et al.
Publicado: (2020)

Clinical and CT features of early stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China
por: Yang, Shuyi, et al.
Publicado: (2020)

Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic
por: Janapatla, Rajendra Prasad, et al.
Publicado: (2021)

Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
por: Fan, Guohui, et al.
Publicado: (2020)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Yang, Hai-Jun, et al.
Publicado: (2020)

Cardiovascular comorbidity and its impact on patients with COVID-19
por: Guan, Wei-jie, et al.
Publicado: (2020)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
por: Milne, Stephen, et al.
Publicado: (2021)

COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
por: Guan, Lili, et al.
Publicado: (2020)

The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis
por: Zhang, Lu, et al.
Publicado: (2022)

High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020)

High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020)

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
por: Chen, Mengfei, et al.
Publicado: (2020)

High-resolution computed tomography features of 17 cases of coronavirus disease 2019 in Sichuan province, China
por: Zhang, Simin, et al.
Publicado: (2020)

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020)

Risk factors for viral RNA shedding in COVID-19 patients
por: Fu, Yu, et al.
Publicado: (2020)

Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
por: Lee, Meng-Rui, et al.
Publicado: (2017)

Job strain and COPD exacerbations: an individual-participant meta-analysis
por: Heikkilä, Katriina, et al.
Publicado: (2014)

Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
por: Boutou, Afroditi K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9dnm4lgfd8fpakmccqv23av7bb